肠道微生态在炎症性肠病诊断与治疗中的应用
被引量:3
摘要
IBD包括UC和CD,是一类肠道非特异性慢性炎性疾病,其病因与发病机制未完全明了。
出处
《中华消化杂志》
CAS
CSCD
北大核心
2013年第12期808-810,共3页
Chinese Journal of Digestion
基金
国家自然科学基金(81270467)
湖北省科技厅重点项目(2013)
参考文献12
-
1Chassaing B, Darfeuille-Michaud A. The commensal microbiota and enteropathogens in the pathogenesis of inflammatory bowel diseases. Gastroenterology, 2011, 140: 1720-1728.
-
2Zhou F, Xia B, Wang F, et al. The prevalence and diagnostic value of perinuclear antineutrophil cytoplasmic antibodies and anti Saccharomyees cerevisiae antibodies in patients with inflammatory bowel disease in China's Mainland. Clin Chim Aeta, 2010, 411:1461-1465.
-
3Frank DN, St Amand AL, Feldman RA, et al. Molecular- phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Aead Sci U S A, 2007, 104:13780-13785.
-
4Willing BP, Dicksved J, Halfvarson J, et al. A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology, 2010, 139:1844-1854.
-
5Papa E, Docktor M, Smillie C, et al. Non invasive mapping of the gastrointestinal microbiota identifies children with inflammatory bowel disease. PLoS One, 2012,7: e39242.
-
6Ciorba MA. A gastroenterologist's guide to probiotics. Clin Gastroenterol Hepatol, 2012,10: 960-968.
-
7陈瑞红,李远发,杨新,夏冰.微生态制剂对溃疡性结肠炎疗效的系统评价[J].胃肠病学,2012,17(4):221-225. 被引量:29
-
8Tursi A, Brandimarte G, Papa A, et al. Treatment of relapsing mild to-moderate ulcerative colitis with the probiotic VSL # 3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study. Am J Gastroenterol, 2010, 105:2218-2227.
-
9Sokol H, Pigneur B, Watterlot L, et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A, 2008, 105: 16731-16736.
-
10Ohkusa T, Kato K, Terao S, et al. Newly developed antibiotic combination therapy for ulcerative colitis: double-blind placebo-controlled multicenter trial. Am J Gastroenterol, 2010, 105:1820-1829.
二级参考文献22
-
1Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences[J]. Gastroenterology, 2004, 126 (6): 1504-1517.
-
2Gob K, Xiao SD. Inflammatory bowel disease: a survey of the epidemiology in Asia[J]. J Dig Dis, 2009, 10 (1): 1-6.
-
3Mowat C, Cole A, Windsor A, et al. Guidelines for the management of inflammatory bowel disease in adults [J]. Gut, 2011, 60 (5): 571-607.
-
4Herias MV, Koninkx JF, Vos JG, et al. Probiotic effects of Lactobacillus casei on DSS-induced ulcerative colitis in mice[J]. Int J Food Microbiol, 2005, 103 (2): 143-155.
-
5Bibiloni R, Fedorak RN, Tannock GW, et al. VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis[J]. Am J Gastroenterol, 2005, 100 (7): 1539-1546.
-
6Huynh HQ, deBruyn J, Guan L, et al. Probiotic preparation VSL#3 induces remission in children with mild to moderate acute ulcerative colitis: a pilot study[J]. Inflamm Bowel Dis, 2009, 15 (5): 760-768.
-
7Adam B, Liebregts T, Holtmann G. Maintaining remission of ulcerative colitis with the probiotic Escherichia Coli Nissle 1917 is as effective as with standard mesalazine (Article in German) [J]. Z Gastroenterol, 2006, 44 (3): 267 -269.
-
8StrausSE等主编.EVIDENCE-BASED MEDICINE: How to Practice and Teach EBM[M].詹思延主译.循证医学实践和教学.北京:北京大学医学出版社.2006:127.
-
9Ishikawa H, Akedo I, Umesaki Y, et al. Randomized controlled trial of the effect of bifidobacteria-fermented milk on ulcerative colitis[J]. J Am Coil Nutr, 2003, 22 (1): 56-63.
-
10Kato K, Mizuno S, Umesaki Y, et al. Randomized placebo-controlled trial assessing the effect of bifidobacteria-fermented milk on active ulcerative colitis [J]. Aliment Pharmacol Ther, 2004, 20 (10): 1133-1141.
共引文献28
-
1周联菲,戴高中.基于肠道菌群中药治疗胃肠道疾病的研究进展[J].智慧健康,2020(8):39-42. 被引量:5
-
2张辉.微生态制剂对溃疡性结肠炎患者治疗前后的临床疗效评价[J].医学信息(医学与计算机应用),2014,0(14):523-524.
-
3李琨,张彩凤,夏永华,李贞娟,韩宇.微生态制剂对溃疡性结肠炎的治疗效果及作用机制研究[J].中华胃肠外科杂志,2013,16(4):336-339. 被引量:35
-
4历娜娜,郝微微,温红珠,李佳.肠道菌群与溃疡性结肠炎[J].辽宁中医药大学学报,2013,15(11):101-103. 被引量:10
-
5盛雄,颜珠凤.奥沙拉嗪联合米雅BM片治疗溃疡性结肠炎临床观察[J].浙江中西医结合杂志,2013,23(12):985-987.
-
6柴元亮.双歧三联活菌联合美沙拉嗪治疗轻中度溃疡性结肠炎疗效分析[J].中国现代药物应用,2014,8(1):120-121. 被引量:23
-
7李则春.敏感抗生素联合益生菌对重度溃疡性结肠炎的治疗作用及安全性研究[J].医学综述,2014,20(5):944-946. 被引量:9
-
8于洪迎.双歧杆菌四联活菌片辅助治疗抗生素相关性腹泻疗效观察[J].中国实用乡村医生杂志,2014(13):50-51.
-
9陈彤,李书娟,王鑫,傅新桓.微生态疗法治疗小儿抗生素相关性腹泻效果观察[J].中国实用乡村医生杂志,2018,25(12):70-72. 被引量:1
-
10苟亚妮,金安琴,史琳,熊海芮,韦丽娜,田红岩,黄晓俊.国内溃疡性结肠炎系统评价/Meta分析研究的方法学质量评价[J].循证医学,2014,14(4):219-223. 被引量:1
同被引文献37
-
1中华医学会消化病学分会炎症性肠病协作组,欧阳钦,胡品津,钱家鸣,郑家驹,胡仁伟.对我国炎症性肠病诊断治疗规范的共识意见(2007年,济南)[J].中华消化杂志,2007,27(8):545-550. 被引量:1018
-
2GB14925-2001.实验动物环境及设施[S].2001.
-
3CHEN W, ZHENG R, BAADE P D, et al. Cancer statistics in China, 2015 [J]. CA Cancer J Clin, 2016, 66 (2) : 115 -132.
-
4ARAN V, VICTORINO A P, THULER L C, et al. Colorectal cancer: epidemiology, disease mechanisms and interventions to reduce onset and mortality [ J]. Clin Colorectal Cancer, 2016.
-
5KYRO C, SKEIE G, LOFT S, et al. Adherence to a healthy Nordic food index is associated with a lower incidence of colorectal cancer in women: the Diet, Cancer and Health cohort study [ J ]. Br J Nutr, 2013, 109 (5): 920-927.
-
6LIU Z, BROOKS R S, CIAPPIO E D, et al. Diet - induced obesity elevates colonic TNF - alpha in mice and is accompanied by an activation of Wnt signaling: a mechanism for obesity - associated colorectal cancer [ Jl. J Nutr Biochem, 2012, 23 (10) : 1207 -1213.
-
7O'KEEFE S J, LI J V, LAHTI L, et al. Fat, fibre and cancer risk in African Americans and rural Africans [J]. Nat Commun, 2015, 6 : 6342.
-
8SUNG M K, YEON J Y, PARK S Y, et al. Obesity - induced metabolic stresses in breast and colon cancer [ J ]. Ann N Y Acad Sci, 2011, 1229:61-68.
-
9WEBER C. Nutrition. Diet change alters microbiota and might affect cancer risk [ J ]. Nat Rev Gastroenterol Hepatol, 2015, 12 (6) : 314.
-
10ARTHUR J C, JOBIN C. The complex interplay between inflammation, the mierobiota and eolorectal cancer[J]. Gut blierobes, 2013, 4 (3): 253-258.
引证文献3
-
1夏阳,朱庆超,汪昱,彭佳远,钱海鑫.高脂饮食引发肠道菌群结构改变与结直肠癌发生的相关性研究[J].中国全科医学,2016,19(20):2473-2480. 被引量:13
-
2黎莉,杨卫文,谭松,刘正勇,何天兰.不同治疗方法对溃疡性结肠炎愈合质量的影响[J].贵州医药,2016,40(10):1068-1070. 被引量:1
-
3郭江芳.肠道益生菌辅助美沙拉嗪治疗炎症性肠病的临床效果[J].深圳中西医结合杂志,2017,27(22):87-88. 被引量:6
二级引证文献20
-
1韩坤.探讨炎症性肠病临床治疗中采用益生菌与美沙拉嗪联合治疗的效果[J].世界最新医学信息文摘,2020(103):26-27. 被引量:1
-
2李奇,刘杰,林洪生,王宜.基于中医理论的结直肠癌患者食疗营养建议[J].中医杂志,2017,58(20):1746-1749. 被引量:11
-
3梁辰飞.胆酸通过诱导肠道低度炎性反应激活IL-6/STAT3通路在肠腺瘤癌变中的作用[J].中国老年学杂志,2018,38(4):928-930. 被引量:2
-
4吴永梅,李文娟,罗酩,张霁雯,沈伟忠.血胰岛素样生长因子和胰岛素抵抗指数测定在大肠癌癌前病变诊疗中的价值[J].中国肿瘤临床与康复,2018,25(8):972-975. 被引量:3
-
5李竞.姜黄通过肠道菌群改善机体脂质代谢作用的实验研究[J].新中医,2018,50(11):15-18. 被引量:4
-
6孙长豹,刘志静,刘飞,杜鹏,侯俊财.食物成分对肠道菌群结构的影响[J].食品研究与开发,2018,39(9):178-182. 被引量:17
-
7陈春晓,曾长镜,邓冬梅.美沙拉嗪与益生菌联合治疗IBD患者的临床效果观察[J].当代医学,2019,25(2):79-81. 被引量:12
-
8王梦頔,胡芳.高膳食纤维饮食和高脂饮食对大鼠回肠造口术术后恢复的影响[J].医学食疗与健康,2019,0(8):19-22.
-
9李莎莎,李芳,王卫峰,李凡.地中海饮食与结直肠癌的相关研究[J].医学信息,2019,32(15):6-9. 被引量:4
-
10赵微,张峰睿,缪应雷.炎症性肠病与肠道微生态[J].胃肠病学,2019,24(6):381-384. 被引量:5
-
1陈厚玲.酚妥拉明治疗小儿毛细支气管炎的疗效观察[J].华北煤炭医学院学报,2007,9(4):527-528. 被引量:1
-
2刘英晓,王立,休双玲.IL-6与2型糖尿病大血管病变的相关性[J].中国老年学杂志,2010,30(17):2513-2515. 被引量:3
-
3王新莲.蒙脱石散联合叶酸治疗小儿秋季腹泻的疗效观察[J].基层医学论坛,2012,16(32):4265-4266.
-
4郭佳,黄宗文.急性胰腺炎与肠道微生态[J].临床消化病杂志,2005,17(2):99-100. 被引量:1
-
5李瑾,林雪,王帆,冯爵荣.肠道微生态与炎症性肠病[J].医学新知,2017,27(2):102-104. 被引量:1
-
6黄丽群.溃疡性结肠炎发病机制概述[J].现代养生,2015,0(6):31-33.
-
7刘俊.溃疡性结肠炎的病因与发病机制[J].中国乡村医生,2000,15(4):15-16.
-
8李文勇,艾涛,邱绍勤,田德英.肠道微生态与肝硬化并发症[J].中西医结合肝病杂志,2007,17(2):127-128. 被引量:2
-
9邢慧.肠道微生态与炎症性肠病的研究进展[J].胃肠病学和肝病学杂志,2016,25(7):729-732. 被引量:3
-
10张波.中西医结合治疗溃疡性结肠炎36例[J].健康大视野(医学版),2013,21(2):78-78.